Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Barry Davies

Newcastle AuthorsTitleYearFull text
Dominic Jones
Dr Mark Wade
Jim Grey
Dr Sirintra Nakjang
Wenrui Guo
et al.		Development and exploitation of a novel mutant androgen receptor modelling strategy to identify new targets for advanced prostate cancer therapy2015
Dr Simon Bomken
Dr Barry Davies
Mike Cole
Dr Katrina Wood
Maritsa McDermott
et al.		Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival2011
Simon Dovedi
Emeritus Professor John Kirby
Dr Barry Davies
Professor Hing Leung
John Kelly
Celecoxib has Potent Antitumour Effects as a Single Agent and in Combination with BCG Immunotherapy in a Model of Urothelial Cell Carcinoma2008
Dr Simon Bomken
Dr Barry Davies
Dr Katrina Wood
Professor Deborah Tweddle
Tumour necrosis following chemotherapy in neuroblastoma correlates with MYC-N status but not survival2007
Professor Richard Edmondson
John Monaghan
Dr Barry Davies
Gonadotropins mediate DNA synthesis and protection from spontaneous cell death in human ovarian surface epithelium2006
Islay Steele
Professor Richard Edmondson
Professor Hing Leung
Dr Barry Davies
Ligands to FGF receptor 2-IIIb induce proliferation, motility, protection from cell death and cytoskeletal rearrangements in epithelial ovarian cancer cell lines2006
Pallavi Mehrotra
Dr Sarah Johnson
Emerita Professor Janet Wilson
Dr Barry Davies
Professor Thomas Lennard
Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy2006
Simon Dovedi
Emeritus Professor John Kirby
Dr Helen Maitland
Dr Barry Davies
John Kelly
Cyclooxygenase-2 inhibition: A potential mechanism for increasing the efficacy of bacillus Calmette-Guerin immunotherapy for bladder cancer2005
Dr Johnny Roughan
Emeritus Professor Paul Flecknell
Dr Barry Davies
Behavioural assessment of the effects of tumour growth in rats and the influence of tne analgesics carprofen and meloxicam2004
Dr Gordon Strathdee
Dr Barry Davies
Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene2004
Jose Dominguez-Escrig
John Kelly
Professor David Neal
Dr Sonya King
Dr Barry Davies
Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer2004
Pallavi Mehrotra
Dr Sarah Johnson
Emerita Professor Janet Wilson
Dr Barry Davies
Professor Thomas Lennard
Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms2004
Alice Evans
Professor Thomas Lennard
Dr Barry Davies
High-mobility group protein 1(Y): Metastasis-associated or metastasis-inducing?2004
Dr Barry Davies
Gene products involved in metastasis of bladder cancer2003
Dr Barry Davies
Islay Steele
Professor Richard Edmondson
Dr Simon Zwolinski
Dr Gabriele Saretzki
et al.		Immortalisation of human ovarian surface epithelium with telomerase and temperature-senstitive SV40 large T antigen2003
12